Nuveen Asset Management, LLC Organogenesis Holdings Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 774,363 shares of ORGO stock, worth $2.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

774,363

Previous 182,107 325.22%

Holding current value

$2.41 Million

Previous $509,000 334.97%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.42 - $3.24 $1.43 Million - $1.92 Million	592,256 Added 325.22%	774,363 $2.21 Million
Q4 2023 Feb 14, 2024	SELL	$1.97 - $4.21 $104,193 - $222,666	-52,890 Reduced 22.51%	182,107 $744,000
Q3 2023 Nov 14, 2023	BUY	$2.34 - $4.43 $125,826 - $238,209	53,772 Added 29.67%	234,997 $747,000
Q1 2023 May 15, 2023	SELL	$1.89 - $2.93 $157,474 - $244,127	-83,320 Reduced 31.5%	181,225 $386,000
Q4 2022 Feb 14, 2023	SELL	$2.48 - $3.43 $298,348 - $412,635	-120,302 Reduced 31.26%	264,545 $712,000
Q3 2022 Nov 14, 2022	SELL	$3.14 - $6.43 $51,238 - $104,924	-16,318 Reduced 4.07%	384,847 $1.25 Million
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $2.3 Million - $3.96 Million	-486,136 Reduced 54.79%	401,165 $1.96 Million
Q1 2022 May 16, 2022	SELL	$6.47 - $9.57 $1.41 Million - $2.09 Million	-218,252 Reduced 19.74%	887,301 $6.69 Million
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $735,923 - $1.1 Million	81,588 Added 7.97%	1,105,553 $10.1 Million
Q3 2021 Nov 12, 2021	BUY	$13.71 - $17.18 $1.42 Million - $1.78 Million	103,745 Added 11.27%	1,023,965 $17.1 Million
Q2 2021 Aug 16, 2021	SELL	$14.92 - $23.23 $686,245 - $1.07 Million	-45,995 Reduced 4.76%	920,220 $15.3 Million
Q1 2021 May 17, 2021	BUY	$7.33 - $21.06 $6.48 Million - $18.6 Million	884,258 Added 1078.93%	966,215 $17.6 Million
Q4 2020 Feb 16, 2021	BUY	$3.63 - $7.53 $128,770 - $267,119	35,474 Added 76.32%	81,957 $617,000
Q3 2020 Nov 16, 2020	BUY	$3.29 - $4.58 $1,589 - $2,212	483 Added 1.05%	46,483 $178,000
Q2 2020 Aug 14, 2020	BUY	$2.86 - $4.61 $56,456 - $91,001	19,740 Added 75.17%	46,000 $177,000
Q1 2020 May 14, 2020	SELL	$2.92 - $5.31 $662 - $1,205	-227 Reduced 0.86%	26,260 $84,000
Q2 2019 Aug 15, 2019	BUY	$6.58 - $8.69 $174,284 - $230,172	26,487 New	26,487 $201,000

Others Institutions Holding ORGO

# of Institutions

117

Shares Held

63.2M

Call Options Held

25K

Put Options Held

23.2K

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $407M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Organogenesis Holdings Inc. Transaction History